Literature DB >> 19807500

Why study pharmacoeconomics?

J A Mauskopf.   

Abstract

Year:  2001        PMID： 19807500     DOI： 10.1586/14737167.1.1.1

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  2 in total

Review 1.  2016 reflections on the favorable cost-benefit of lung cancer screening.

Authors:  Bruce Pyenson; Gabriela Dieguez
Journal:  Ann Transl Med       Date:  2016-04

2.  Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action.

Authors:  Abdulrazaq S Al-Jazairi; Nada S Al-Qadheeb; Aziza Ajlan
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.